chalcone has been researched along with Cell Transformation, Neoplastic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, TE; Lad, R; Srinivasan, B; Xing, C | 1 |
| He, F; Li, X; Liu, S; Liu, Z; Simoneau, AR; Wu, XR; Xu, X; Zi, X | 1 |
| Han, R; He, X | 1 |
3 other study(ies) available for chalcone and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Chalcone; Chalcones; Female; Genes, Reporter; Humans; I-kappa B Kinase; Inhibitory Concentration 50; Interleukin-1 Receptor-Associated Kinases; Luciferases; Lung Neoplasms; Mice; Mice, Nude; NF-kappa B; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2009 |
Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model.
Topics: Animals; Antigens, Polyomavirus Transforming; Apoptosis; Blotting, Southern; Blotting, Western; Cell Proliferation; Cell Transformation, Neoplastic; Chalcone; Chromatography, Liquid; Disease Models, Animal; Female; Humans; Immunoenzyme Techniques; Kava; Male; Mice; Mice, Transgenic; Tandem Mass Spectrometry; Urinary Bladder Neoplasms; Uroplakin II | 2013 |
[Induction differentiation by a new third generation retinoid R9158 on human acute promyelocytic leukemia cell line, NB4].
Topics: Aneuploidy; Antineoplastic Agents; Cell Division; Cell Transformation, Neoplastic; Chalcone; Chalcones; Humans; Leukemia, Promyelocytic, Acute; Retinoids; Translocation, Genetic; Tumor Cells, Cultured | 1998 |